Attwood KM - Search Results

1

Exosomal Thomsen-Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses.

Hsu CC, Su Y, Rittenhouse-Olson K, Attwood KM, Mojica W, Reid ME, Dy GK, Wu Y. Hsu CC, et al. Among authors: attwood km. Cancer Res Commun. 2024 Aug 1;4(8):1933-1945. doi: 10.1158/2767-9764.CRC-23-0505. Cancer Res Commun. 2024. PMID: 39015090 Free PMC article.

2

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy.

Dy GK, Prasad D, Kumar P, Attwood K, Adjei AA. Dy GK, et al. J Thorac Oncol. 2021 Mar;16(3):e19-e20. doi: 10.1016/j.jtho.2020.11.019. J Thorac Oncol. 2021. PMID: 33641724 Free article. Clinical Trial. No abstract available.

3

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors.

Yamauchi T, Hoki T, Oba T, Jain V, Chen H, Attwood K, Battaglia S, George S, Chatta G, Puzanov I, Morrison C, Odunsi K, Segal BH, Dy GK, Ernstoff MS, Ito F. Yamauchi T, et al. Nat Commun. 2021 Mar 3;12(1):1402. doi: 10.1038/s41467-021-21619-0. Nat Commun. 2021. PMID: 33658501 Free PMC article.

4

Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery.

Bouchard EG, Saad-Harfouche FG, Clark N, Colon J, LaValley SA, Reid M, Attwood K, Bansal-Travers M, Glaser K. Bouchard EG, et al. J Cancer Educ. 2023 Jun;38(3):854-862. doi: 10.1007/s13187-022-02197-1. Epub 2022 Jul 15. J Cancer Educ. 2023. PMID: 35840859 Free PMC article.

5

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.

Evans R, Lee K, Wallace PK, Reid M, Muhitch J, Dozier A, Mesa C, Luaces PL, Santos-Morales O, Groman A, Cedeno C, Cinquino A, Fisher DT, Puzanov I, Opyrchal M, Fountzilas C, Dai T, Ernstoff M, Attwood K, Hutson A, Johnson C, Mazorra Z, Saavedra D, Leon K, Lage A, Crombet T, Dy GK. Evans R, et al. Front Oncol. 2022 Aug 3;12:958043. doi: 10.3389/fonc.2022.958043. eCollection 2022. Front Oncol. 2022. PMID: 35992783 Free PMC article.

6

STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer.

Athans S, Krishnan N, Ramakrishnan S, Cortes Gomez E, Lage-Vickers S, Rak M, Kazmierczak Z, Ohm J, Attwood K, Wang J, Woloszynska A. Athans S, et al. Cancer Res Commun. 2022 Oct;2(10):1129-1143. doi: 10.1158/2767-9764.crc-22-0155. Epub 2022 Oct 6. Cancer Res Commun. 2022. PMID: 36275363 Free PMC article.

7

Predictive and Prognostic Implications of Circulating CX3CR1⁺ CD8⁺ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.

Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal BH, Dy GK, Ito F. Abdelfatah E, et al. Cancer Res Commun. 2023 Mar 30;3(3):510-520. doi: 10.1158/2767-9764.CRC-22-0383. eCollection 2023 Mar. Cancer Res Commun. 2023. PMID: 37009132 Free PMC article.

8

Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non-Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance.

Deng L, Jiang C, Attwood K, Zhao JJ, Perimbeti S, Hu C, Puzanov I, Dy GK. Deng L, et al. JCO Oncol Pract. 2023 Oct;19(10):871-881. doi: 10.1200/OP.23.00353. Epub 2023 Sep 8. JCO Oncol Pract. 2023. PMID: 37683137 Free PMC article.

9

Improving Guideline-Recommended Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC): Implementing a Patient Navigation and Practice Facilitation Intervention to Promote Health Equity.

Glaser KM, Crabtree-Ide CR, McNulty AD, Attwood KM, Flores TF, Krolikowski AM, Robillard KT, Reid ME. Glaser KM, et al. Among authors: attwood km. Int J Environ Res Public Health. 2024 Jan 24;21(2):126. doi: 10.3390/ijerph21020126. Int J Environ Res Public Health. 2024. PMID: 38397617 Free PMC article.

10

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Awidi M, Mier-Hicks A, Perimbeti S, Attwood K, Chen H, Jain P, Yau E, Early A, Dy GK. Awidi M, et al. Clin Lung Cancer. 2024 Sep;25(6):509-518. doi: 10.1016/j.cllc.2024.05.003. Epub 2024 May 29. Clin Lung Cancer. 2024. PMID: 38879394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters